American Century Companies
VERA icon

American Century Companies’s Vera Therapeutics VERA Stock Holding History

American Century Companies’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.3M Sell
728,330
-4,369
-0.6% -$188K 0.02% 998
2025
Q4 		$37.1M Buy
732,699
+24,276
+3% +$862K 0.02% 864
2025
Q3 		$20.6M Sell
708,423
-6,005
-0.8% -$139K 0.01% 1135
2025
Q2 		$16.8M Buy
714,428
+336,978
+89% +$7.58M 0.01% 1169
2025
Q1 		$9.07M Sell
377,450
-51,490
-12% -$1.65M 0.01% 1356
2024
Q4 		$18.1M Buy
428,940
+42,526
+11% +$1.88M 0.01% 1096
2024
Q3 		$17.1M Sell
386,414
-966
-0.2% -$36.7K 0.01% 1093
2024
Q2 		$14M Buy
+387,380
New +$15.4M 0.01% 1103

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies's VERA Position: Q1 2026 in Review

American Century Companies reduced its Vera Therapeutics (VERA) stake by 0.6% in Q1 2026, selling an estimated $188K and leaving 728,330 shares worth $29.3M. The position accounts for 0.02% of the portfolio, ranked #998.

American Century Companies first reported a position in VERA in Q2 2024 and has held it in 8 quarters since. The position peaked at $37.1M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • American Century Companies held 728,330 shares of Vera Therapeutics worth $29.3M as of Q1 2026.
  • American Century Companies sold 4,369 Vera Therapeutics shares in Q1 2026, an estimated $188K.
  • Vera Therapeutics made up 0.02% of American Century Companies's portfolio in Q1 2026, its #998 holding.
  • American Century Companies first reported a position in Vera Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • American Century Companies's Vera Therapeutics position peaked at $37.1M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.